Published in Infect Immun on December 28, 2009
Persistent G. lamblia impairs growth in a murine malnutrition model. J Clin Invest (2013) 1.81
Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infect Immun (2011) 1.38
Preliminary Characterization of the Transcriptional Response of the Porcine Intestinal Cell Line IPEC-J2 to Enterotoxigenic Escherichia coli, Escherichia coli, and E. coli Lipopolysaccharide. Comp Funct Genomics (2010) 1.11
Advances in understanding Giardia: determinants and mechanisms of chronic sequelae. F1000Prime Rep (2015) 0.90
Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit gamma interferon-mediated cellular activation. Infect Immun (2012) 0.86
Role of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli. PLoS One (2012) 0.85
Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with Giardia lamblia and enteroaggregative Escherichia coli. PLoS Pathog (2017) 0.82
Cytokine patterns in paediatric patients presenting serious gastrointestinal and respiratory bacterial infections. Cent Eur J Immunol (2014) 0.80
Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. Am J Clin Nutr (2011) 0.78
Modulatory effects of vasoactive intestinal peptide on intestinal mucosal immunity and microbial community of weaned piglets challenged by an enterotoxigenic Escherichia coli (K88). PLoS One (2014) 0.78
Giardia: both a harmless commensal and a devastating pathogen. J Clin Invest (2013) 0.77
Lactobacillus acidophilus alleviates the inflammatory response to enterotoxigenic Escherichia coli K88 via inhibition of the NF-κB and p38 mitogen-activated protein kinase signaling pathways in piglets. BMC Microbiol (2016) 0.75
Giardia: a pathogen or commensal for children in high-prevalence settings? Curr Opin Infect Dis (2016) 0.75
Resistance to reinfection in mice as a vaccine model for giardiasis. Hum Vaccin Immunother (2014) 0.75
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest (1995) 7.68
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
Biology of Giardia lamblia. Clin Microbiol Rev (2001) 5.35
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol (2007) 5.14
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev (2005) 5.02
Regulatory T cells and mechanisms of immune system control. Nat Med (2004) 4.23
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol (1990) 3.55
Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol (1997) 2.60
Evaluation of Kato thick-smear technique for quantitative diagnosis of helminth infections. Am J Trop Med Hyg (1968) 2.58
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun (1999) 2.50
Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev (2005) 2.49
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun (2004) 2.32
Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil. Lancet (1994) 2.28
Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med (2007) 2.18
Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol (2006) 2.11
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun (2000) 1.94
Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun (2006) 1.87
Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J Immunol (2002) 1.80
Role of bacterial intimin in colonic hyperplasia and inflammation. Science (1999) 1.71
IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol (2008) 1.66
Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect Immun (2001) 1.60
Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun (2002) 1.54
Vitamin A supplementation has divergent effects on norovirus infections and clinical symptoms among Mexican children. J Infect Dis (2007) 1.50
T-cell-dependent control of acute Giardia lamblia infections in mice. Infect Immun (2000) 1.48
Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect Immun (2008) 1.41
Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2005) 1.32
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis (2003) 1.30
Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J Infect Dis (2002) 1.25
Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology (2002) 1.21
Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes. FEMS Microbiol Immunol (1988) 1.12
A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol (2005) 1.06
Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol (2004) 1.02
Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches. J Infect Dis (1996) 1.01
Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J Infect Dis (2006) 0.97
A comparison of mucosal inflammatory responses to Giardia muris in resistant B10 and susceptible BALB/c mice. Parasite Immunol (1997) 0.96
Comparison of antibody and cytokine responses to primary Giardia muris infection in H-2 congenic strains of mice. Infect Immun (1996) 0.94
Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. Pediatrics (2007) 0.94
The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea. J Nutr (2006) 0.93
Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol (2008) 0.93
Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A. Infect Immun (2003) 0.88
Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis. Int J Parasitol (2007) 0.88
Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits. Infect Immun (2005) 0.86
Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens. Future Microbiol (2008) 0.83
Faecal contamination and enterotoxigenic Escherichia coli in street-vended chili sauces in Mexico and its public health relevance. Epidemiol Infect (2002) 0.81
Long-term systemic and mucosal antibody responses measured in BALB/c mice following intranasal challenge with viable enterotoxigenic Escherichia coli. FEMS Immunol Med Microbiol (2006) 0.78
Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med (2003) 5.38
Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection. Lancet Infect Dis (2005) 2.67
The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 2.60
Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis (2012) 2.30
Iron and zinc supplementation does not improve parent or teacher ratings of behavior in first grade Mexican children exposed to lead. J Pediatr (2005) 2.24
Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol (2004) 1.98
The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol (2011) 1.86
Rifaximin--a novel antimicrobial for enteric infections. J Infect (2005) 1.79
Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol (2003) 1.77
Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. Bull World Health Organ (2011) 1.74
Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73
Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis (2009) 1.70
Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis (2002) 1.64
Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann Intern Med (2002) 1.61
Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol (2003) 1.55
A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol (2006) 1.54
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol (2010) 1.50
Vitamin A supplementation has divergent effects on norovirus infections and clinical symptoms among Mexican children. J Infect Dis (2007) 1.50
Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg (2009) 1.49
Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med (2014) 1.47
The role of diet in the treatment of travelers' diarrhea: a pilot study. Clin Infect Dis (2004) 1.45
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol (2007) 1.41
In utero alcohol exposure and prediction of alcohol disorders in early adulthood: a birth cohort study. Arch Gen Psychiatry (2006) 1.39
The controversial and short-lived early use of rehydration therapy for cholera. Clin Infect Dis (2008) 1.38
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis (2006) 1.38
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther (2010) 1.35
Impact of micronutrient deficiencies on obesity. Nutr Rev (2009) 1.34
In utero and postnatal maternal smoking and asthma in adolescence. Epidemiology (2006) 1.34
Deficits in cognitive function and achievement in Mexican first-graders with low blood lead concentrations. Environ Res (2005) 1.31
A global pandemic influenza vaccine action plan. Vaccine (2006) 1.31
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis (2003) 1.30
Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J Infect Dis (2002) 1.25
Blood lead, anemia, and short stature are independently associated with cognitive performance in Mexican school children. J Nutr (2004) 1.24
Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders. Clin Infect Dis (2006) 1.21
Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med (2004) 1.21
Association of diarrheagenic Escherichia coli Pathotypes with infection and diarrhea among Mexican children and association of atypical Enteropathogenic E. coli with acute diarrhea. J Clin Microbiol (2008) 1.21
Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J Clin Microbiol (2002) 1.19
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother (2011) 1.18
Enteroaggregative Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol (2004) 1.18
Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis (2002) 1.15
Asymptomatic norovirus infection in Mexican children. J Clin Microbiol (2006) 1.13
Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol (2014) 1.12
Network of dendritic cells within the muscular layer of the mouse intestine. Proc Natl Acad Sci U S A (2005) 1.10
Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol (2006) 1.09
A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis (2007) 1.09
Drug-resistant diarrheogenic Escherichia coli, Mexico. Emerg Infect Dis (2005) 1.08
A double-blind, randomized, clinical trial of the effect of vitamin A and zinc supplementation on diarrheal disease and respiratory tract infections in children in Mexico City, Mexico. Am J Clin Nutr (2006) 1.07
A longitudinal study of child mental health and problem behaviours at 14 years of age following unplanned pregnancy. Psychiatry Res (2010) 1.06
A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol (2006) 1.06
Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol (2011) 1.05
Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico. J Travel Med (2002) 1.03
Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol (2005) 1.03
Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries. J Med Microbiol (2007) 1.03
Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol (2004) 1.02
Maternal smoking during pregnancy predicts nicotine disorder (dependence or withdrawal) in young adults - a birth cohort study. Aust N Z J Public Health (2009) 1.02
Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era. Clin Infect Dis (2012) 1.02
The family as a determinant of stunting in children living in conditions of extreme poverty: a case-control study. BMC Public Health (2004) 1.00
Zinc, vitamin A, and vitamin C status are associated with leptin concentrations and obesity in Mexican women: results from a cross-sectional study. Nutr Metab (Lond) (2012) 0.99
Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother (2008) 0.99
Bile acids improve the antimicrobial effect of rifaximin. Antimicrob Agents Chemother (2010) 0.97
Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Ther (2005) 0.97
Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J Infect Dis (2006) 0.97
The search for effective treatment of Clostridium difficile infection. N Engl J Med (2011) 0.95
Increase in body mass index and waist circumference is associated with high blood pressure in children and adolescents in Mexico city. Arch Med Res (2009) 0.95
Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. Pediatrics (2007) 0.94
Early detection of pandemic (H1N1) 2009, Bangladesh. Emerg Infect Dis (2012) 0.93
The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea. J Nutr (2006) 0.93
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother (2010) 0.93
Adolescent problem behaviours predicting DSM-IV diagnoses of multiple substance use disorder. Findings of a prospective birth cohort study. Soc Psychiatry Psychiatr Epidemiol (2008) 0.93
Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol (2008) 0.93
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol (2010) 0.92
The patient presenting with acute dysentery--a systematic review. J Infect (2012) 0.92
Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med (2008) 0.92
Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren: a randomized, placebo-controlled trial. Pediatrics (2006) 0.92
Vitamin A supplementation reduces the monocyte chemoattractant protein-1 intestinal immune response of Mexican children. J Nutr (2006) 0.92
Toxin synthesis by Clostridium difficile is regulated through quorum signaling. MBio (2015) 0.91
Advances in defining etiology and new therapeutic approaches in acute diarrhea. J Infect (2007) 0.91
Current and future developments in travelers' diarrhea therapy. Expert Rev Anti Infect Ther (2006) 0.91
Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis (2011) 0.90
Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses. J Med Virol (2006) 0.90
Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Clin Gastroenterol Hepatol (2004) 0.89
Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med (2007) 0.89
Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis (2009) 0.88
Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients. Inflamm Allergy Drug Targets (2011) 0.87
The efficacy of a local ascorbic acid-rich food in improving iron absorption from Mexican diets: a field study using stable isotopes. Am J Clin Nutr (2003) 0.86
Puffer fish poisoning (tetrodotoxin) in Bangladesh: clinical profile and role of anticholinesterase drugs. Trop Doct (2005) 0.86
Presence of faecal coliforms, Escherichia coli and diarrheagenic E. coli pathotypes in ready-to-eat salads, from an area where crops are irrigated with untreated sewage water. Int J Food Microbiol (2012) 0.86
Puffer fish (Tetrodotoxin) poisoning: an analysis and outcome of six cases. Trop Doct (2007) 0.86
Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study. J Travel Med (2008) 0.85